nateglinide vs octreotide
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of nateglinide and octreotide. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
Drugs and Herbals That May Reduce the Blood-Glucose-Lowering Effect of Nateglinide and Increase Susceptibility to Hyperglycemia Drugs: Thiazides, corticosteroids, thyroid products, sympathomimetics, somatropin, somatostatin analogues (e.g., lanreotide, octreotide), and CYP inducers (e.g., rifampin, phenytoin and St John's Wort).
Starlix
Sandostatin
Nateglinide (Starlix) helps control blood sugar in adults with type 2 diabetes. It should be used with diet and exercise.
Octreotide is a drug that mimics a natural hormone in your body. It is used to treat certain conditions caused by too much of certain hormones.
Nateglinide is used to help lower blood sugar in adults who have type 2 diabetes. You should also follow a diet and exercise plan while taking this medicine. Nateglinide should not be used if you have type 1 diabetes or diabetic ketoacidosis.
Octreotide is used to lower growth hormone and insulin-like growth factor-1 in people with acromegaly who haven't responded to other treatments. It also helps manage severe diarrhea and flushing caused by carcinoid tumors. Additionally, it can treat watery diarrhea caused by VIPomas (tumors that release vasoactive intestinal peptide).
Nateglinide helps your pancreas release insulin after you eat. Insulin helps move sugar from your blood into your cells. This lowers your blood sugar levels after meals.
This medicine works by mimicking somatostatin, a natural hormone in your body. It reduces the amount of certain hormones, like growth hormone, that your body makes. By doing this, it helps control the symptoms caused by having too much of these hormones.
- • Upper respiratory infection
- • Back pain
- • Flu symptoms
- • Dizziness
- • Joint pain
- • Gallbladder problems
- • Slow heart rate
- • Diarrhea
- • Loose stools
- • Nausea
- Blood Glucose Increased 76
- Diarrhoea 63
- Dyspnoea 62
- Fatigue 56
- Nausea 54
- Diarrhoea 526
- Death 375
- Nausea 345
- Fatigue 305
- Malignant Neoplasm Progression 235
Nateglinide can cause low blood sugar (hypoglycemia). Take it before meals and skip the dose if you skip the meal to help prevent this. There have been no studies showing that nateglinide lowers your risk of heart or blood vessel problems.
Octreotide can cause heart problems, including a higher risk of certain types of heart block. Your doctor may monitor your heart if you receive this drug intravenously. It can also cause gallbladder problems, high or low blood sugar, and thyroid issues. Tell your doctor right away if you notice new or worsening symptoms.
It is not known if nateglinide can harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. Nateglinide is not recommended if you are breastfeeding because it may cause low blood sugar in the baby.
There is limited information about the safety of octreotide during pregnancy. Talk to your doctor if you are pregnant or plan to become pregnant. It is not known if octreotide passes into breast milk, so talk to your doctor about breastfeeding while using this medicine.
Also Compare, Nearby Drugs
Compare nateglinide with
How to Read This nateglinide vs octreotide Comparison
nateglinide is classified in the Meglitinide drug class, while octreotide sits within the Somatostatin Analog class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, nateglinide has 311 submissions while octreotide has 1,786. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to octreotide can reduce the blood-sugar-lowering effects of nateglinide. this may lead to higher blood sugar levels than normal.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for nateglinide or octreotide.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.